Endothelial function in patients with peripheral vascular disease: influence of prostaglandin E1
Authors:
- 1 November 2002
- journal article
- clinical trial
- Published by Elsevier in Prostaglandins, Leukotrienes and Essential Fatty Acids
- Vol. 67 (5) , 277-281
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Endothelial dysfunction in type 2 diabetes mellitus subjects with peripheral artery diseaseInternational Journal of Cardiology, 2001
- Endothelial dysfunction: Clinical implicationsProgress in Cardiovascular Diseases, 1997
- The microcirculation in atherogenesisCardiovascular Research, 1996
- The role of nitric oxide and other endothelium-derived vasoactive substances in vascular diseaseProgress in Cardiovascular Diseases, 1995
- Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis.Circulation Research, 1991
- Regulatory Functions of the Vascular EndotheliumNew England Journal of Medicine, 1990
- INTRAVENOUS PROSTAGLANDIN E1 IN SEVERE PERIPHERAL VASCULAR DISEASEThe Lancet, 1976
- Metabolism of prostaglandins A1 and E1 in man.Journal of Clinical Investigation, 1975
- FEMORAL-ARTERY INFUSION OF PROSTAGLANDIN E1 IN SEVERE PERIPHERAL VASCULAR DISEASEThe Lancet, 1973
- Inactivation of Prostaglandins by the LungsNature, 1970